**US4132163001 - ADR - After market: 4 -0.01 (-0.25%)**

Taking everything into account, **HMY** scores **3** out of 10 in our fundamental rating. **HMY** was compared to 969 industry peers in the **Metals & Mining** industry. The financial health of **HMY** is medium. Also its profitability is quite bad. **HMY** is not valued too expensively and it also shows a decent growth rate.

*Note: HMY has only limited data available, so a full analysis was not possible, which makes the total rating unfair.*

With a **Forward Price/Earnings Ratio** of **10.40**, the valuation of **HMY** can be described as very reasonable.

When comparing the current price to the book value of **HMY**, we can conclude it is valued correctly. It is trading at **1.50** times its book value.

Compared to an average industry price book ratio of 1.68, **HMY** is valued in line with its industry peers.

When comparing the **Enterprise Value to EBITDA** ratio of **HMY** to the average industry ratio of 6.23, **HMY** is valued in line with its industry peers.

Price/Book (1.5) VS Industry: 52% outperformed.

6,836.00

0.03

Enterprise Value/ EBITDA (6.14) VS Industry: 51% outperformed.

374.61

0.07

The **Earnings Per Share** is expected to grow by **23.33%** on average over the next 5 years. This is a very strong growth

The **Revenue** has been growing by **17.23%** on average over the past 5 years. This is quite good.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

Past | Future | ||||||
---|---|---|---|---|---|---|---|

5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |

EPS | N/A | N/A | -127.62% | 22.92% | 31.35% | 23.33% | N/A |

Revenue | 17.23% | 16.58% | 2.19% | 5.58% | 7.66% | 2.52% | N/A |

Although this is true,

The Altman-Z score is in line with the industry averages, which is at **2.51**.

Compared to an average industry Current Ratio of 2.56, **HMY** is worse placed to pay its short term obligations than its industry peers.

When comparing the Quick Ratio of **HMY** to the average industry Current Ratio of **2.16**, **HMY** is less able to pay its short term obligations than its industry peers.

The Piotroski-F score of **HMY** is **3.00**. This is a low score and indicates issues in the health and profitability of **HMY**.

Debt/Equity (0.11) VS Industry: 20% outperformed.

4.14

0.00

Quick Ratio (0.94) VS Industry: 27% outperformed.

0.00

178.59

Current Ratio (1.51) VS Industry: 32% outperformed.

0.00

178.59

Altman-Z (2.7) VS Industry: 50% outperformed.

-22,403.48

2,514.55

With a **Dividend Yield** of **0.84**, **HMY** pays less dividend than the industry average, which is at **2.10**. 91% of the companies listed in the same industry pay a better dividend than **HMY**!

With a **Dividend Yield** of **0.84**, **HMY** pays less dividend than the S&P500 average, which is at **2.60**.

The earnings of **HMY** are negative and hence is the payout ratio. **HMY** will probably not be able to sustain this dividend level.

Dividend Yield (0.84%) VS Industry: 9% outperformed.

0.27

24.74

NYSE:HMY (3/29/2023, 7:12:13 PM)**-0.09 (-2.2%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryMetals & Mining

Earnings (Last)03-01 2023-03-01

Earnings (Next)N/A N/A

Inst Owners29.29%

Inst Owner Change-7.23%

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap2.48B

Analysts45.71

Price Target3.21 (-19.95%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 0.84% |

Dividend Growth(5Y)N/A

DP-40.87%

Div Incr Years1

Div Non Decr Years1

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

PT rev (1m)0.52%

PT rev (3m)8.09%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)1.22%

EPS NY rev (3m)0.97%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)1.89%

Revenue NY rev (3m)1.89%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | 10.4 | ||

P/S | 1.06 | ||

P/FCF | 63.44 | ||

P/OCF | 6.51 | ||

P/B | 1.5 | ||

P/tB | 1.5 | ||

EV/EBITDA | 6.14 |

EPS(TTM)-0.09

EYN/A

EPS(NY)0.39

Fwd EY9.62%

FCF(TTM)0.06

FCFY1.58%

OCF(TTM)0.62

OCFY15.37%

SpS3.8

BVpS2.67

TBVpS2.67

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | N/A | ||

ROE | N/A | ||

ROIC | 7.7% | ||

ROICexc | 8.18% | ||

ROICexgc | 8.19% | ||

OM | 9.41% | ||

PM | N/A | ||

GM | 12.15% |

ROICexgc(3y)9.12%

ROICexcg growth 3Y41.23%

ROICexcg growth 5Y41.64%

ROICexc(3y)9.04%

ROICexc growth 3Y41.95%

ROICexc growth 5Y42.11%

OM growth 3Y29.8%

OM growth 5Y25%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y14.42%

GM growth 5Y10.56%

F-Score3

Asset Turnover0.91

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.11 | ||

Debt/FCF | 5.14 | ||

Debt/EBITDA | 0.47 | ||

Cap/Depr | 168.72% | ||

Profit Quality | N/A | ||

Current Ratio | 1.51 | ||

Quick Ratio | 0.94 | ||

Altman-Z | 2.7 |

F-Score3

WACC17.25%

ROIC/WACC0.47

Cap/Depr(3y)134.75%

Cap/Depr(5y)141.27%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

Growth

EPS 1Y-127.62%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q-247.78%

EPS Next Y22.92%

EPS Next 2Y31.35%

EPS Next 3Y23.33%

EPS Next 5YN/A

Revenue growth 1Y2.19%

Revenue growth 3Y16.58%

Revenue growth 5Y17.23%

Revenue growth Q2Q2.73%

Revenue Next Year5.58%

Revenue Next 2Y7.66%

Revenue Next 3Y2.52%

Revenue Next 5YN/A

EBIT growth 1Y-35.53%

EBIT growth 3Y51.33%

EBIT growth 5Y46.53%

EBIT Next Year115.54%

EBIT Next 3Y35.14%

EBIT Next 5YN/A

FCF growth 1Y-82.41%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-24.57%

OCF growth 3Y13.96%

OCF growth 5Y12.73%

*Find stocks with similar Fundamental rating on the USA*

*Find the competitors with the best fundamentals on the USA*

*Find the competitors with the best valuation on the USA*

*Find the competitors with the best dividend on the USA*